scholarly journals Correction to: An Integrated In Vitro–In Silico Approach for Silver Nanoparticle Dosimetry in Cell Cultures

2020 ◽  
Vol 48 (4) ◽  
pp. 1441-1441
Author(s):  
Daniele Poli ◽  
Giorgio Mattei ◽  
Nadia Ucciferri ◽  
Arti Ahluwalia
2020 ◽  
Vol 48 (4) ◽  
pp. 1271-1280
Author(s):  
Daniele Poli ◽  
Giorgio Mattei ◽  
Nadia Ucciferri ◽  
Arti Ahluwalia

2020 ◽  
Vol 259 ◽  
pp. 113880 ◽  
Author(s):  
Kathryn Jalink ◽  
Sammi Sham Yin Cheng ◽  
S. Ben Ireland ◽  
M.A.F. Louise Meunier

BIOMAT 2014 ◽  
2015 ◽  
Author(s):  
M. A. C. HUERGO ◽  
B. MOGLIA ◽  
E.V. ALBANO ◽  
N. GUISONI

Author(s):  
Andreas Knote ◽  
Sabine C. Fischer ◽  
Sylvain Cussat-Blanc ◽  
Florian Niebling ◽  
David Bernard ◽  
...  
Keyword(s):  

Author(s):  
Markus Boel ◽  
Oscar J. Abilez ◽  
Ahmed N Assar ◽  
Christopher K. Zarins ◽  
Ellen Kuhl

Author(s):  
Jaynthy C. ◽  
N. Premjanu ◽  
Abhinav Srivastava

Cancer is a major disease with millions of patients diagnosed each year with high mortality around the world. Various studies are still going on to study the further mechanisms and pathways of the cancer cell proliferation. Fucosylation is one of the most important oligosaccharide modifications involved in cancer and inflammation. In cancer development increased core fucosylation by FUT8 play an important role in cell proliferation. Down regulation of FUT8 expression may help cure lung cancer. Therefore the computational study based on the down regulation mechanism of FUT8 was mechanised. Sapota fruit extract, containing 4-Ogalloylchlorogenic acid was used as the inhibitor against FUT-8 as target and docking was performed using in-silico tool, Accelrys Discovery Studio. There were several conformations of the docked result, and conformation 1 showed 80% dock score between the ligand and the target. Further the amino acids of the inhibitor involved in docking were studied using another tool, Ligplot. Thus, in-silico analysis based on drug designing parameters shows that the fruit extract can be studied further using in-vitro techniques to know its pharmacokinetics.


2019 ◽  
Author(s):  
Filip Fratev ◽  
Denisse A. Gutierrez ◽  
Renato J. Aguilera ◽  
suman sirimulla

AKT1 is emerging as a useful target for treating cancer. Herein, we discovered a new set of ligands that inhibit the AKT1, as shown by in vitro binding and cell line studies, using a newly designed virtual screening protocol that combines structure-based pharmacophore and docking screens. Taking together with the biological data, the combination of structure based pharamcophore and docking methods demonstrated reasonable success rate in identifying new inhibitors (60-70%) proving the success of aforementioned approach. A detail analysis of the ligand-protein interactions was performed explaining observed activities.<br>


Sign in / Sign up

Export Citation Format

Share Document